Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, Texas
Medline (Nasdaq: MDLN) broke ground on a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expanding its U.S. network of 45 distribution centers.
Rhea-AI Summary
Medline (Nasdaq: MDLN) broke ground on a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expanding its U.S. network of 45 distribution centers. The facility is expected to be fully operational in Q2 2027 and will include advanced automation such as AutoStore.
The site is Medline's second in the Dallas–Fort Worth area, supports next-day delivery to 95% of U.S. customers, and follows the company’s December 2025 initial public offering.
Positive
- Constructing a 1.2 million sq. ft. distribution center in Midlothian, Texas
- Expansion increases national DC network beyond 45 centers, strengthening distribution footprint
- New DC expected to be fully operational in Q2 2027, adding regional capacity in Dallas–Fort Worth
- Facility will deploy advanced automation including AutoStore, aligning with other large distribution centers
- Next-day delivery to 95% of U.S. customers supported by expanded network and owned fleet
Negative
- None.
Details
News Market Reaction – MDLN
On Mar 11, the day this news came out, MDLN closed 1.14% below the previous close.
Data tracked by StockTitan Argus for the Mar 11 session.
Key Figures
- New DC size
- 1.2 million sq. ft
- Midlothian, Texas distribution center announcement
- U.S. DC network
- 45 distribution centers
- Existing national network before new Midlothian site
- Warehouse footprint
- 26 million sq. ft
- Current U.S. warehouse space cited by Medline
- Inventory days
- 80 days
- On-hand inventory across Medline’s network
- Delivery coverage
- 95% of customers
- Next-day delivery coverage in the U.S.
- Go-live timing
- Q2 2027
- Expected full operation of Midlothian distribution center
- FY2025 net sales
- $28.4B (+11.5%)
- Full year 2025 results
- FY2025 Adjusted EBITDA
- $3.5B (+3.2%)
- Full year 2025 results
Historical Context
-
Closing of secondary offering by selling holders at $41.00 per share.
-
Recognition of top-performing distribution centers and safety-focused SAFE awards.
-
Pricing of 75,000,000 Class A shares at $41.00 by selling holders.
-
Launch of underwritten offering of 75,000,000 Class A shares by sponsors.
-
Strong FY2025 sales growth with guidance for 2026 organic sales and EBITDA.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
class a common stock financial
class b common stock financial
form 4 regulatory
form 3 regulatory
restricted stock unit financial
common units financial
incentive units financial
initial public offering financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growth
This second distribution center in the
"Today we have more than 26 million square feet of warehouse space in the
The
"Our network of distribution centers strategically located across the country enables us to provide next-day delivery to
About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in
Contact:
Carroll Henning
(847) 226-0587
chenning@medline.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/medlines-growth-continues-as-it-breaks-ground-on-1-2-million-sq-ft-distribution-center-in-midlothian-texas-302711339.html
SOURCE Medline
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.